Haleon projects a gradual revenue and profit growth towards the second half of 2025, despite strong end-year sales in 2024. The company recorded 4-6 per cent projected organic revenue growth, with ...

Haleon reported FY24 revenue of £11.23B ($14.19B), down 0.6%, with 5% organic growth. Adjusted operating profit fell 6.5% to £2.50B. 2025 guidance projects 4-6% organic revenue growth, with ...

Good morning, everyone. Welcome to Haleon's Full Year 2024 Q&A call. I'm Jo Russell, Head of Investor Relations. And I'm joined this morning by Brian McNamara, Chief Executive Officer; and Dawn ...

British consumer healthcare group Haleon disappointed investors after the Sensodyne toothpaste maker said 2025 revenue growth would be weighted to the second half of the year, sending shares down ...

(Alliance News) - Haleon PLC on Thursday saw organic sales growth accelerate in the fourth quarter but cautioned growth in 2025 would be weighted to the second-half. Pretax profit rose 17% to GBP1 ...

In this article, we are going to take a look at where Haleon plc (NYSE:HLN) stands against the other pharma stocks. Healthcare, which includes numerous businesses that offer patient care ...

Consumer healthcare giant Haleon has reported a strong financial performance for 2024, with organic revenue growth of five per cent. However, revenue declined by 0.6 per cent on a reported basis ...

Haleon po0sted a higher pretax profit for 2024 despite lower revenue, and said it expected further organic revenue and profit growth this year. The consumer-health giant, which was spun out of GSK ...

We recently compiled a list of the 12 Best Low Price Pharma Stocks To Invest In Right Now. In this article, we are going to take a look at where Haleon plc (NYSE:HLN) stands against the other pharma ...

(Reuters) - British consumer healthcare group Haleon on Thursday said 2025 revenue and profit growth would be weighted to the second half of the year, overshadowing a strong end to 2024 and sending ...

Haleon is scheduled to report results for 2024 on Thursday. Here is what you need to know. SALES FORECAST: The British consumer-healthcare business is expected to book revenue of 11.22 billion ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...